The effect of topical cyclosporine in lichen planus of the hair

Phase 2

• Conditions: lichen planopilaris.; Lichen planopilaris; L66.1

• Registration Number: IRCT20170809035597N3
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 18

Inclusion Criteria

patients between 13 and 60 years of age
histopathologic diagnosis of lichen planopilaris

Exclusion Criteria

Topical or oral treatment in the last month
The presence of serious concomitant diseases such as uncontrolled diabetes, uncontrolled hypertension, malignancies, retinal diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Disease severity. Timepoint: One, three, five and six months after the start of treatment. Method of measurement: based on LPPAI (lichen planopilaris activity index) criteria.

Secondary Outcome Measures

Name	Time	Method
Physician satisfaction. Timepoint: One, three, five and six months after the start of treatment. Method of measurement: Based on the 5-point physician global assessment score using clinical and dermatoscopic images.;Patient satisfaction. Timepoint: One, three, five and six months after the start of treatment. Method of measurement: Based on the 5-point patient global assessment score.;Tolerability. Timepoint: One, three, five and six months after the start of treatment. Method of measurement: Using a checklist (yes, no).;Adverse effects. Timepoint: One, three, five and six months after the start of treatment. Method of measurement: Using a checklist.